Bausch & Lomb CEO: the AI hysteria is nothing new
Brent Saunders is one of the most successful value creators in the history of health care. As the CEO and Chairman of Bausch + Lomb, Brent oversees a team of approximately 13,000 people who deliver innovative solutions to protect and enhance the gift of sight for millions of individuals worldwide.
He has been the driving force behind numerous health care and pharmaceutical mega deals that have resulted in tremendous benefits for patients, shareholders and employees. These include Allergan plc.’s $63 billion acquisition by Abbvie Inc, Forest Laboratories Inc.’s $25 billion merger with Actavis plc and Actavis’ $66 billion acquisition of Allergan.











